ArticlePediatric pulmonology2025
Caffeine Protects Newborn Rat Lungs Against the Effects of Hyperoxia and Intra-Amniotic Enterotoxin.
Article in Pediatric pulmonology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Caffeine Protects Against Hyperoxia-Induced Structural Lung Injury and Restores Alveolar Development in Neonatal Rats.Antioxidants (Basel, Switzerland) · 2025Article
- Caffeine Protects Newborn Rat Lungs Against the Effects of Hyperoxia and Intra-Amniotic Enterotoxin.Pediatric pulmonology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionBronchopulmonary dysplasia (BPD) has a multifactorial etiology with prenatal and/or postnatal factors contributing to the pathogenesis, and there is no completely effective treatment to prevent or treat this condition. Our objective was to evaluate the effects of caffeine treatment in two BPD-like rat models using prenatal and postnatal factors.
methodsIn a BPD-like model induced by a prenatal factor, endotoxin (ETX) or saline was administered to pregnant rats by intra-amniotic (i.a.) injection on day 20 of pregnancy, and pups were delivered by cesarean section at term (day 22). On the other hand, for a BPD-like model induced by a postnatal factor, the pups were maintained in hyperoxia (80%-85%) (HYP) or normoxia (room air) for 14 days after natural birth. In both models, caffeine (20 mg/kg) was administered every other day until postnatal day 14. On postnatal day 14, we assessed lung function (peak-inspiratory-pressure, compliance), lung structure (radial-alveolar-count, mean-linear-intercept, pulmonary-vessel-density), and pulmonary hypertension.
resultThe effects of i.a. ETX or HYP were evident in neonatal rats not receiving treatment, these animals showing impaired lung function and lung structure and developing pulmonary hypertension compared to results after i.a. saline administration or normoxia. Postnatal caffeine administration was associated with significantly better outcomes in terms of lung compliance, alveolarization, lung vascular growth, and pulmonary hypertension.
conclusionIn a BPD-like model induced by prenatal (i.a. ETX) or postnatal (HYP) factors, caffeine administration preserved lung function and structure and prevented pulmonary hypertension. These findings confirm that caffeine (the drug most commonly prescribed in neonatal care units) may provide an effective strategy for BPD prevention when prenatal or postnatal factors are involved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.